Get the latest tech news
OpenAI and the FDA are reportedly discussing AI for drug evaluations
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug evaluations.
According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation (CDE). The CDE regulates over-the-counter and prescription drugs in the U.S. Associates from Elon Musk’s DOGE have reportedly been part of the talks as well. TechCrunch Space Every Monday, gets you up to speed on the latest advances in aerospace.
Or read this on TechCrunch
